What is the recommended protocol for weaning a patient off nortriptyline (tricyclic antidepressant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Wean Nortriptyline

Discontinue nortriptyline over 10 to 14 days to limit withdrawal symptoms, reducing the dose gradually rather than stopping abruptly. 1

Tapering Protocol

The standard approach is to taper over 10-14 days, which represents the evidence-based timeframe for tricyclic antidepressant discontinuation. 1 This guideline applies specifically to nortriptyline as a tricyclic antidepressant (TCA).

Specific Dosing Strategy

  • Start by reducing the current dose by approximately 10-25% every 3-7 days until complete discontinuation is achieved 1
  • For patients on higher doses (e.g., 75-100 mg/day), begin with 25 mg decrements every 3-7 days 1
  • For patients on lower doses (e.g., 25-50 mg/day), reduce by 10 mg increments every 3-7 days 1
  • The final step should reach the lowest available dose before complete discontinuation 2

Important Timing Considerations

  • Do NOT use alternate-day dosing when tapering nortriptyline - this approach causes pronounced fluctuations in drug levels and significantly increases withdrawal symptom risk 3
  • Maintain daily dosing throughout the taper, simply reducing the daily dose amount 3

Monitoring During Taper

Withdrawal Symptoms to Watch For

  • Gastrointestinal distress (most common with nortriptyline) 4
  • Flu-like symptoms, insomnia, nausea 2
  • Anxiety, irritability, restlessness 5
  • Sensory disturbances and imbalance 2

These symptoms typically emerge within 1-3 days of dose reduction and may last 1-2 weeks 2

Management of Withdrawal Symptoms

  • If withdrawal symptoms occur, hold at the current dose for several additional days before continuing the taper 1
  • Consider slowing the taper rate to 10% reductions every 7-10 days if symptoms are problematic 1
  • Adjunctive medications can help manage specific symptoms: gabapentin for anxiety/irritability, trazodone for insomnia, or mirtazapine for sleep disturbances 1

Special Populations and Circumstances

Longer Duration Therapy

  • Patients who have been on nortriptyline for many months or years may require a more extended tapering schedule beyond the standard 10-14 days 2, 6
  • Consider extending the taper to 4-8 weeks for patients on long-term therapy (>6 months) 6

Pediatric Patients

  • Gradual tapering in children and adolescents effectively prevents withdrawal symptoms in most cases 4
  • Use the same general principles but may require closer monitoring 4

Patients with Cardiac Disease

  • Exercise particular caution given nortriptyline's potential for cardiotoxic effects 1
  • Monitor for any cardiac symptoms during the taper 1

Critical Pitfalls to Avoid

  • Never stop nortriptyline abruptly - this significantly increases withdrawal symptom risk 1
  • Avoid alternate-day dosing strategies - these cause dangerous fluctuations in receptor occupancy 3
  • Do not confuse withdrawal symptoms with depression recurrence - withdrawal emerges quickly (1-3 days) and diminishes over time, while depression recurrence develops gradually and persists 2
  • Do not taper multiple psychotropic medications simultaneously - if the patient is on other medications, wean one at a time 7

When to Seek Additional Support

  • If signs of depression recurrence emerge (gradual onset, persistent symptoms), prompt medical evaluation is needed 2
  • Suicidal thoughts or severe mood disturbances during tapering warrant immediate medical attention 2
  • Consider slower tapering or temporary dose stabilization if withdrawal symptoms are severe 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Citalopram Discontinuation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A randomized trial of nortriptyline for smoking cessation.

Archives of internal medicine, 1998

Research

Strategies to reduce use of antidepressants.

British journal of clinical pharmacology, 2021

Guideline

Weaning Protocol for Benzodiazepines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.